Prostate News Archive
27-Mar-2008
MRI findings help forecast prostate cancer prognosis (News-Medical-Net)
Magnetic resonance imaging (MRI) findings in patients about to undergo radiation therapy for prostate cancer can help predict the likelihood that the cancer will return and spread post-treatment, according to a new study published in the April issue of the journal Radiology. MRI helps predict return of prostate cancer, study finds (The Star-Ledger)
Men with prostate cancer who undergo an MRI prior to radiation may be able to better predict the likelihood of their cancer returning and spreading after treatment, a study being published today has found. Oxford BioMedica Report Encouraging New Phase II Trial Results With Trovax(R) In Prostate Cancer (Medical News Today)
Oxford BioMedica (LSE: OXB), a leading gene therapy company, announces encouraging new data from its first Phase II trial of TroVax in prostate cancer. TroVax is Oxford BioMedica's lead cancer immunotherapy product, which is being developed in collaboration with sanofi-aventis. MRI Can Be Predictor of Post-Treatment Prostate Cancer Spread (HealthDay via Yahoo! News)
TUESDAY, March 25 (HealthDay News) -- Magnetic resonance imaging (MRI) can help predict the risk of cancer recurrence in prostate cancer patients who are about to have radiation therapy, a new U.S. study says.
Back to Prostate News Archive
